Search Results - "Chester, Kerry"

Refine Results
  1. 1

    A plug-and-play approach to antibody-based therapeutics via a chemoselective dual click strategy by Maruani, Antoine, Smith, Mark E.B., Miranda, Enrique, Chester, Kerry A., Chudasama, Vijay, Caddick, Stephen

    Published in Nature communications (31-03-2015)
    “…Although recent methods for the engineering of antibody–drug conjugates (ADCs) have gone some way to addressing the challenging issues of ADC construction,…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4

    Tuning the Hydrolytic Stability of Next Generation Maleimide Cross-Linkers Enables Access to Albumin-Antibody Fragment Conjugates and tri-scFvs by Forte, Nafsika, Livanos, Maria, Miranda, Enrique, Morais, Maurício, Yang, Xiaoping, Rajkumar, Vineeth S, Chester, Kerry A, Chudasama, Vijay, Baker, James R

    Published in Bioconjugate chemistry (21-02-2018)
    “…We describe investigations to expand the scope of next generation maleimide cross-linkers for the construction of homogeneous protein–protein conjugates…”
    Get full text
    Journal Article
  5. 5

    Next generation maleimides enable the controlled assembly of antibody-drug conjugates via native disulfide bond bridging by Schumacher, Felix F, Nunes, João P M, Maruani, Antoine, Chudasama, Vijay, Smith, Mark E B, Chester, Kerry A, Baker, James R, Caddick, Stephen

    Published in Organic & biomolecular chemistry (07-10-2014)
    “…The advent of Adcetris™ and Kadcyla™, two recently FDA-approved antibody-drug conjugates (ADCs), in the clinic has had a major impact on the treatment of…”
    Get more information
    Journal Article
  6. 6

    A Simple and Robust Single-Step Method for CAR-Vδ1 γδT Cell Expansion and Transduction for Cancer Immunotherapy by Ferry, Gabrielle M., Agbuduwe, Charles, Forrester, Megan, Dunlop, Sophie, Chester, Kerry, Fisher, Jonathan, Anderson, John, Barisa, Marta

    Published in Frontiers in immunology (31-05-2022)
    “…The γδT cell subset of peripheral lymphocytes exhibits potent cancer antigen recognition independent of classical peptide MHC complexes, making it an…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11

    Acid-cleavable thiomaleamic acid linker for homogeneous antibody-drug conjugation by Castañeda, Lourdes, Maruani, Antoine, Schumacher, Felix F, Miranda, Enrique, Chudasama, Vijay, Chester, Kerry A, Baker, James R, Smith, Mark E B, Caddick, Stephen

    “…In this communication we describe a novel acid-cleavable linker strategy for antibody-drug conjugation. Functional disulfide bridging of the single interchain…”
    Get more information
    Journal Article
  12. 12
  13. 13

    Homogeneous Bispecifics by Disulfide Bridging by Hull, Elizabeth A, Livanos, Maria, Miranda, Enrique, Smith, Mark E. B, Chester, Kerry A, Baker, James R

    Published in Bioconjugate chemistry (20-08-2014)
    “…We report on a chemical platform to generate site-specific, homogeneous, antibody–antibody conjugates by targeting and bridging disulfide bonds. A bispecific…”
    Get full text
    Journal Article
  14. 14

    scFv biofunctionalized nanoparticles to effective and safe targeting of CEA-expressing colorectal cancer cells by Silveira, Maria José, Martins, Cláudia, Cruz, Tânia, Castro, Flávia, Amorim-Costa, Ângela, Chester, Kerry, Oliveira, Maria José, Sarmento, Bruno

    Published in Journal of nanobiotechnology (02-10-2023)
    “…Abstract Colorectal cancer (CRC) is one of the deadliest cancers worldwide, with the 5 year survival rate in metastatic cases limited to 12%. The design of…”
    Get full text
    Journal Article
  15. 15

    Antibody-drug conjugates - a perfect synergy by Adair, John R, Howard, Philip W, Hartley, John A, Williams, David G, Chester, Kerry A

    Published in Expert opinion on biological therapy (01-09-2012)
    “…There is a great unmet need for effective new treatments in cancer, which continues to be a major cause of death. Antibody-drug conjugates (ADCs) are emerging,…”
    Get more information
    Journal Article
  16. 16

    Aryloxymaleimides for cysteine modification, disulfide bridging and the dual functionalization of disulfide bonds by Marculescu, Cristina, Kossen, Hanno, Morgan, Rachel E, Mayer, Patrick, Fletcher, Sally A, Tolner, Berend, Chester, Kerry A, Jones, Lyn H, Baker, James R

    “…Tuning the properties of maleimide reagents holds significant promise in expanding the toolbox of available methods for bioconjugation. Herein we describe…”
    Get more information
    Journal Article
  17. 17
  18. 18

    Targeted photodynamic therapy with multiply‐loaded recombinant antibody fragments by Bhatti, Manpreet, Yahioglu, Gokhan, Milgrom, Lionel R., Garcia‐Maya, Mitla, Chester, Kerry A., Deonarain, Mahendra P.

    Published in International journal of cancer (01-03-2008)
    “…Current photodynamic therapy (PDT) of cancer is limited by inefficiencies involved in specifically targeting photosensitizers to tumors. Although antibodies…”
    Get full text
    Journal Article
  19. 19

    Homogeneous antibody fragment conjugation by disulfide bridging introduces ‘spinostics’ by Schumacher, Felix F., Sanchania, Vishal A., Tolner, Berend, Wright, Zoë V. F., Ryan, Chris P., Smith, Mark E. B., Ward, John M., Caddick, Stephen, Kay, Christopher W. M., Aeppli, Gabriel, Chester, Kerry A., Baker, James R.

    Published in Scientific reports (22-03-2013)
    “…A major obstacle to the efficient production of antibody conjugates for therapy and diagnosis is the non-ideal performance of commonly used chemical methods…”
    Get full text
    Journal Article
  20. 20